Gynecologic Pathology

Overview

Coming February 2026: Pre-Order Today!
CME Guide to Gynecologic Pathology Advances

In this online CME program, you’ll encounter the latest discoveries and diagnostic challenges in gynecologic pathology, focusing on biopsies, resections, and gestational trophoblastic neoplasia. You’ll examine commonly encountered specimens such as endometrial and cervical biopsies, as well as the complex mesenchymal lesions that often pose diagnostic difficulties.

Organized by anatomic location and neoplasia subtypes, the Gynecologic Pathology course — part of our Masters of Pathology Series — will help you build a structured and practical approach to interpreting a wide range of gynecologic specimens. It’s continuing medical education that:

• Ensures you’re current with novel emerging diagnostic classification schemes and the newly developed endometrial staging system
• Previews the upcoming 6th edition of the WHO blue book, offering insight into key updates
• Demonstrates how to integrate a wide array of immunohistochemical stains and molecular assays alongside morphologic features in surgical pathology

Topics / Speakers

Classification of Vulvar Squamous Lesions – Non-Invasive - Jaclyn Watkins, MD, MS

Classification and Staging of Vulvar Squamous Cell Carcinoma - Jaclyn Watkins, MD, MS

Vulvovaginal Mesenchymal Lesions – Tumors - Marisa R. Nucci MD

Classification of Squamous Lesion - Eric Yang, MD PhD

Classification of Cervical Glandular Lesions – Non-Invasive - Kay Park, MD

Slide Session – Non-Invasive Glandular Lesions of the Cervix - Kay Park, MD

Classification of Invasive Cervical Adenocarcinoma - Kay Park, MD

Staging of Cervical Carcinomas - Kay Park, MD

Slide Session – HPVA Adenocarcinomas - Kay Park, MD

Slide Session – HPVI Adenocarcinomas - Kay Park, MD

Approach to the Endometrial Biopsy - Jaclyn Watkins, MD, MS

Diagnosis of Atypical Hyperplasia-EIN and Progestin Therapy - Brooke E. Howitt, MD

Endometrial Carcinoma – Molecular Classification - Brooke E. Howitt, MD

Endometrial Carcinoma – Integration of Histotype and Molecular Subtype - Brooke E. Howitt, MD

FIGO 2023 Endometrial Cancer Staging - Joseph Rabban MD MPH

High Risk Endometrial Cancers that Mimic Low Grade Endometrioid Carcinoma - Joseph Rabban MD, MPH

Smooth Muscle Tumors of the Uterus and Mimics - Brooke E. Howitt, MD

Endometrial Stromal and Non-Smooth Muscle Mesenchymal Neoplasms - Brooke E. Howitt, MD

Adenosarcoma and Mimics - Brooke E. Howitt, MD

Pre-Invasive Lesions of the Fallopian Tube - Brooke E. Howitt, MD

Slide Session – Lesions of the Fallopian Tube - Brooke E. Howitt, MD

Serous Borderline-Low-Grade Serous Carcinomas of the Ovary and Implants - Teri A. Longacre, MD

Approach to Tumor Typing of High Risk Ovarian Cancers - Joseph Rabban MD, MPH

Sex Cord Stromal Tumors of the Ovary – Part 1 - Jaclyn Watkins, MD, MS

Sex Cord Stromal Tumors of the Ovary – Part 2 - Jaclyn Watkins, MD, MS

Endometriosis and Endometriosis-Associated Cancers - Jaclyn Watkins, MD, MS

First Trimester POCs – What Not to Miss - Jaclyn Watkins, MD, MS

Gestational Trophoblastic Disease - Ann Folkins, MD

Biomarker Interpretation in Gynecologic Tumors - Brooke E. Howitt, MD

Faculty

Course Director

Speakers

Accreditation

Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

Oakstone Publishing designates this enduring material for AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity meets the American Board of Pathology's (ABPath) Continuing Certification program requirements for Part II (CME) Lifelong Learning.

Date of Original Release: TBD
Credit Expiration Date: TBD

CME credit is awarded upon successful completion of a course evaluation and post-test.

Learning Objectives

At the completion of this course, clinicians should be able to:

• Describe the classification of vulvar squamous neoplasia including staging approaches for vulvar cancer
• Describe the classification of cervical squamous and glandular neoplasia including staging approaches for vulvar cancer
• Determine the TCGA molecular classification in endometrial carcinoma and how this influences FIGO stage
• Recognize preinvasive endometrial lesions and diagnosis in the setting of progestin therapy
• Determine appropriate ancillary testing in the diagnosis of uterine mesenchymal neoplasms
• Describe features of serous tubal intraepithelial carcinoma and other p53abnormal lesions of the fallopian tube
• Assess low-grade serous neoplasia and implants
• Describe the features and ancillary testing in ovarian carcinomas
• Classify sex cord stromal tumors of the ovary accurately
• Recognize features of molar pregnancy in POC specimens
• Describe classification of gestational trophoblastic tumors
• Outline the interpretation of immunohistochemical biomarkers commonly used in gynecologic pathology diagnoses

Intended Audience

This educational activity is intended for training and practicing pathologists.

Quick Facts

Masters of Pathology Series Provider: Oakstone CME

Course Director:

Brooke E. Howitt, MD

Credits: Earn AMA PRA Category 1 Credits™